<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Huang X</submitter><funding>Science and technology project of Fuzhou Medical College of Nanchang University</funding><funding>Jiangxi Province university humanities and social science research project</funding><funding>Science and Technology Research Project of Jiangxi Provincial Department of Education</funding><funding>Project supported by Jiangxi Science and Technology Support Plan</funding><funding>Science and technology project of Jiangxi Provincial Administration of Traditional Chinese Medicine</funding><pagination>e090728</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11552014</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(11)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Lung cancer continues to be a common form of cancer worldwide and a primary contributor to cancer-related fatalities. Non-small cell lung cancer (NSCLC) is the most prevalent form, making up 80% to 85% of newly identified malignant lung tumours, and remains a major concern for worldwide health. Surgical resection is the preferred treatment for localised NSCLC, but more than one-third of patients present with locally advanced, unresectable tumours. Concurrent radiation therapy and chemotherapy are believed to offer the potential for prolonged disease-free and overall survival to those patients. However, the results are inconsistent, and systematic meta-analysis is lacking to evaluate its treatment effect comprehensively. Therefore, we will conduct a meta-analysis to eva</pubmed_abstract><journal>BMJ open</journal><pubmed_title>Three-dimensional conformal radiation therapy with concurrent chemotherapy for stage III non-small cell lung cancer: protocol for a systematic review and meta-analysis.</pubmed_title><pmcid>PMC11552014</pmcid><funding_grant_id>JY21240</funding_grant_id><funding_grant_id>FYKJ202404</funding_grant_id><funding_grant_id>GJJ208902</funding_grant_id><funding_grant_id>2022B1103</funding_grant_id><funding_grant_id>20133BBF60078</funding_grant_id><pubmed_authors>Xu L</pubmed_authors><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Chen Q</pubmed_authors><pubmed_authors>Huang S</pubmed_authors><pubmed_authors>Zhu J</pubmed_authors><pubmed_authors>Huang X</pubmed_authors><pubmed_authors>Ren Y</pubmed_authors><pubmed_authors>Xu J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Three-dimensional conformal radiation therapy with concurrent chemotherapy for stage III non-small cell lung cancer: protocol for a systematic review and meta-analysis.</name><description>&lt;h4>Introduction&lt;/h4>Lung cancer continues to be a common form of cancer worldwide and a primary contributor to cancer-related fatalities. Non-small cell lung cancer (NSCLC) is the most prevalent form, making up 80% to 85% of newly identified malignant lung tumours, and remains a major concern for worldwide health. Surgical resection is the preferred treatment for localised NSCLC, but more than one-third of patients present with locally advanced, unresectable tumours. Concurrent radiation therapy and chemotherapy are believed to offer the potential for prolonged disease-free and overall survival to those patients. However, the results are inconsistent, and systematic meta-analysis is lacking to evaluate its treatment effect comprehensively. Therefore, we will conduct a meta-analysis to eva</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-07-16T18:55:43.858Z</modification><creation>2025-04-04T00:32:58.228Z</creation></dates><accession>S-EPMC11552014</accession><cross_references><pubmed>39515858</pubmed><doi>10.1136/bmjopen-2024-090728</doi></cross_references></HashMap>